BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26549344)

  • 1. Epigenetic regulation of IQGAP2 promotes ovarian cancer progression via activating Wnt/β-catenin signaling.
    Deng Z; Wang L; Hou H; Zhou J; Li X
    Int J Oncol; 2016 Jan; 48(1):153-60. PubMed ID: 26549344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
    Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
    Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y
    Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Singh AK; Chandra N; Bapat SA
    Clin Cancer Res; 2015 Nov; 21(22):5151-63. PubMed ID: 26130461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.
    Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH
    Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
    Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
    PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line.
    Yen HY; Tsao CW; Lin YW; Kuo CC; Tsao CH; Liu CY
    Sci Rep; 2019 Nov; 9(1):17267. PubMed ID: 31754130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQ-domain GTPase-activating protein 1 promotes the malignant phenotype of invasive ductal breast carcinoma via canonical Wnt pathway.
    Zhao HY; Han Y; Wang J; Yang LH; Zheng XY; Du J; Wu GP; Wang EH
    Tumour Biol; 2017 Jun; 39(6):1010428317705769. PubMed ID: 28618949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
    Wu N; Wei J; Wang Y; Yan J; Qin Y; Tong D; Pang B; Sun D; Sun H; Yu Y; Sun W; Meng X; Zhang C; Bai J; Chen F; Geng J; Lee KY; Fu S; Jin Y
    PLoS One; 2015; 10(11):e0143659. PubMed ID: 26618703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer.
    Kim SJ; Tae CH; Hong SN; Min BH; Chang DK; Rhee PL; Kim JJ; Kim HC; Kim DH; Kim YH
    Mol Carcinog; 2015 Dec; 54(12):1748-57. PubMed ID: 25620232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
    Gnatenko DV; Xu X; Zhu W; Schmidt VA
    PLoS One; 2013; 8(8):e71826. PubMed ID: 23951254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.